← Leaderboards
Polly Chang
Sri International
$121,906,628
Attributed
$121,906,628
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $17.4M · FY2015–23$20M$15M$10M$5M$0
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$121,906,628 · 2
By mechanism
N01$121,906,628 · 2
Top collaborators
No co-investigators on record.
Most similar at Sri International
Same institution · by research overlap
- Carol E Green$19,982,282
- Hua Lin$2,214,560
- Michal Avital-Shmilovici$370,293
- Xiaohe Liu$979,575
Others in their field
Top investigators on “Services”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,236,423,805
- Leonard Freedman · Leidos Biomedical Research, Inc.$868,224,440
- Larry Arthur$689,089,782
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Bambra Strokes · Ppd Development Lp$526,656,217
- Mitchell J Malone · Texas A&M Research Foundation$353,400,900
Research focus
ServicesContractsRadiation InjuriesAnimal EfficacyEfficacy StudyProduct DevelopmentPharmacology StudyMedical CountermeasureNuclearRadiationAwardStability TestingNational Institute Of Allergy And Infectious DiseaseContract ServicesResearch And DevelopmentGood Laboratory PracticeSafetyEvaluationStrategic PlanningAuthorityDocumentationMedical LicensureUnited States Dept. Of Health And Human ServicesUnited States Food And Drug Administration
Grant awards (38)
ANIMAL MODEL DEVELOPMENT AND EFFICACY TESTING OF CANDIDATE MCMS$7,751,590
N01 · FY2023 · AI · contact PI
ANIMAL MODEL DEVELOPMENT AND EFFICACY TESTING$3,433,599
N01 · FY2023 · AI · contact PI
RADIOLOGICAL/NUCLEAR MEDICAL COUNTERMEASURE (MCM) PRODUCT DEVELOPMENT SUPPORT, ADMINISTRATIVE AND TECHNICAL SUPPORT$2,513,024
N01 · FY2023 · AI · contact PI
NON-CLINICAL STUDIES IN SUPPORT OF IND/NDA/BLA SUBMISSIONS$1,928,640
N01 · FY2023 · AI · contact PI
TASK ORDER B-1, ANIMAL MODEL DEVELOPMENT AND EFFICACY TESTING OF CANDIDATE MCMS$1,057,669
N01 · FY2023 · AI · contact PI
DECORPORATION MCM PHASE 1 CLINICAL SAFETY STUDY$363,202
N01 · FY2023 · AI · contact PI
ANIMAL MODEL DEVELOPMENT AND EFFICACY TESTING$8,651,823
N01 · FY2022 · AI · contact PI
NON-CLINICAL STUDIES IN SUPPORT OF IND/NDA/BLA SUBMISSIONS$2,117,267
N01 · FY2022 · AI · contact PI
RADIOLOGICAL/NUCLEAR MEDICAL COUNTERMEASURE (MCM) PRODUCT DEVELOPMENT SUPPORT, ADMINISTRATIVE AND TECHNICAL SUPPORT$1,962,573
N01 · FY2022 · AI · contact PI
RADIOLOGICAL/NUCLEAR MEDICAL COUNTERMEASURE (MCM) PRODUCT DEVELOPMENT SUPPORT, ADMINISTRATIVE AND TECHNICAL SUPPORT$827,461
N01 · FY2022 · AI · contact PI
TASK ORDER B-1, ANIMAL MODEL DEVELOPMENT AND EFFICACY TESTING OF CANDIDATE MCMS$679,231
N01 · FY2022 · AI · contact PI
RADIATION/NUCLEAR MEDICAL COUNTERMEASURE (MCM) PRODUCT DEVELOPMENT SUPPORT SERVICES. TASK ORDER B-1, ANIMAL MODEL DEVELOPMENT AND INITIAL EFFICACY TESTING OF CANDIDATE MCMS.$46,991
N01 · FY2022 · AI · contact PI
ANIMAL MODEL DEVELOPMENT AND EFFICACY TESTING$11,180,527
N01 · FY2021 · AI · contact PI
DECORPORATION MCM PHASE 1 CLINICAL SAFETY STUDY$3,097,464
N01 · FY2021 · AI · contact PI
RADIOLOGICAL/NUCLEAR MEDICAL COUNTERMEASURE (MCM) PRODUCT DEVELOPMENT SUPPORT, ADMINISTRATIVE AND TECHNICAL SUPPORT$1,910,455
N01 · FY2021 · AI · contact PI
ANIMAL MODEL DEVELOPMENT AND INITIAL EFFICACY TESTING$1,188,122
N01 · FY2021 · AI · contact PI
RADIOLOGICAL/NUCLEAR MEDICAL COUNTERMEASURE (MCM) PRODUCT DEVELOPMENT SUPPORT, ADMINISTRATIVE AND TECHNICAL SUPPORT$11,922,084
N01 · FY2020 · AI · contact PI
ANIMAL MODEL DEVELOPMENT AND INITIAL EFFICACY TESTING$2,870,980
N01 · FY2020 · AI · contact PI
RADIOLOGICAL/NUCLEAR MEDICAL COUNTERMEASURE (MCM) PRODUCT DEVELOPMENT SUPPORT, ADMINISTRATIVE AND TECHNICAL SUPPORT$1,784,263
N01 · FY2020 · AI · contact PI
Radiation/Nuclear Medical Countermeasure (MCM) Product Development Support Services$480,156
N01 · FY2020 · AI · contact PI
RADIATION/NUCLEAR MEDICAL COUNTERMEASURE (MCM) PRODUCT DEVELOPMENT SUPPORT SERVICES. FORMULATION OF 3,4,3-LI(1,2-HOPO)$77,853
N01 · FY2020 · AI · contact PI
ANIMAL MODEL DEVELOPMENT AND INITIAL EFFICACY TESTING$5,315,249
N01 · FY2019 · AI · contact PI
Radiation/Nuclear Medical Countermeasure (MCM) Product Development Support Services, Animal Model Development and Initial Efficacy Testing$2,254,565
N01 · FY2019 · AI · contact PI
RADIATION/NUCLEAR MEDICAL COUNTERMEASURE (MCM) PRODUCT DEVELOPMENT SUPPORT SERVICES. TASK ORDER A-1 ADMINISTRATIVE AND TECHNICAL SUPPORT$1,999,679
N01 · FY2019 · AI · contact PI
Radiation/Nuclear Medical Countermeasure (MCM) Product Development Support Services$1,999,379
N01 · FY2019 · AI · contact PI
RADIATION/NUCLEAR MEDICAL COUNTERMEASURE (MCM) PRODUCT DEVELOPMENT SUPPORT SERVICES. FORMULATION OF 3,4,3-LI(1,2-HOPO)$23,180
N01 · FY2019 · AI · contact PI
Radiation/Nuclear Medical Countermeasure (MCM) Product Development Support Services, Animal Model Development and Initial Efficacy Testing, 9/25/2018-8/31/2020, $7,086,000$7,086,075
N01 · FY2018 · AI · contact PI
RADIATION/NUCLEAR MEDICAL COUNTERMEASURE (MCM) PRODUCT DEVELOPMENT SUPPORT SERVICES. TASK ORDER A-1 ADMINISTRATIVE AND TECHNICAL SUPPORT$2,310,235
N01 · FY2018 · AI · contact PI
RADIATION/NUCLEAR MEDICAL COUNTERMEASURE (MCM) PRODUCT DEVELOPMENT SUPPORT SERVICES. FORMULATION OF 3,4,3-LI(1,2-HOPO)$49,157
N01 · FY2018 · AI · contact PI
Radiation/Nuclear Medical Countermeasure (MCM) Product Development Support Services$13,081,207
N01 · FY2017 · AI · contact PI
RADIATION/NUCLEAR MEDICAL COUNTERMEASURE (MCM) PRODUCT DEVELOPMENT SUPPORT SERVICES. TASK ORDER A-1 ADMINISTRATIVE AND TECHNICAL SUPPORT$1,710,738
N01 · FY2017 · AI · contact PI
RADIATION/NUCLEAR MEDICAL COUNTERMEASURE (MCM) PRODUCT DEVELOPMENT SUPPORT$530,940
N01 · FY2017 · AI · contact PI
RADIATION/NUCLEAR MEDICAL COUNTERMEASURE (MCM) PRODUCT DEVELOPMENT SUPPORT$7,937,337
N01 · FY2016 · AI · contact PI
RADIATION/NUCLEAR MEDICAL COUNTERMEASURE (MCM) PRODUCT DEVELOPMENT SUPPORT SERVICES. TASK ORDER A-1 ADMINISTRATIVE AND TECHNICAL SUPPORT$1,832,316
N01 · FY2016 · AI · contact PI
RADIATION/NUCLEAR MEDICAL COUNTERMEASURE (MCM) PRODUCT DEVELOPMENT SUPPORT SERVICES. FORMULATION OF 3,4,3-LI(1,2-HOPO)$584,303
N01 · FY2016 · AI · contact PI
RADIATION/NUCLEAR MEDICAL COUNTERMEASURE (MCM) PRODUCT DEVELOPMENT SUPPORT SERVICES. FORMULATION OF RECOMBINANT HUMAN PLEIOTROPHIN (RHPTN)$397,869
N01 · FY2016 · AI · contact PI
RADIATION/NUCLEAR MEDICAL COUNTERMEASURE (MCM) PRODUCT DEVELOPMENT SUPPORT SERVICES. TASK ORDER B-1, ANIMAL MODEL DEVELOPMENT AND INITIAL EFFICACY TESTING OF CANDIDATE MCMS.$6,245,298
N01 · FY2015 · AI · contact PI
RADIATION/NUCLEAR MEDICAL COUNTERMEASURE (MCM) PRODUCT DEVELOPMENT SUPPORT SERVICES. TASK ORDER A-1 ADMINISTRATIVE AND TECHNICAL SUPPORT$2,704,127
N01 · FY2015 · AI · contact PI